Fungerende finansdirekt°r i Biotec Pharmacon, J°rn Lunde, har gjennom sitt heleide selskap LM&C AS kj°pt 11.000 aksjer i Biotec Pharmacon til kurs 19,8182. Ny beholdning er 30 000 aksjer.
Det opplyses i en melding onsdag.
Verdane funds invest in companies with a strong growth potential, mainly within consumer internet, software, energy and advanced industrial sectors. The funds have invested in over 340 companies since 2003.
The team represents a broad range of professional experience. Several team members are former entrepreneurs and others have prior experience from operational positions, management consulting, banking and private equity.